↓ Skip to main content

The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms

Overview of attention for article published in Journal of Translational Medicine, December 2018
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (65th percentile)
  • Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

twitter
1 X user
patent
2 patents

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
96 Mendeley
Title
The ruxolitinib effect: understanding how molecular pathogenesis and epigenetic dysregulation impact therapeutic efficacy in myeloproliferative neoplasms
Published in
Journal of Translational Medicine, December 2018
DOI 10.1186/s12967-018-1729-7
Pubmed ID
Authors

Graeme Greenfield, Suzanne McPherson, Ken Mills, Mary Frances McMullin

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 96 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 96 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 13%
Student > Ph. D. Student 10 10%
Researcher 10 10%
Student > Master 10 10%
Other 7 7%
Other 17 18%
Unknown 30 31%
Readers by discipline Count As %
Medicine and Dentistry 23 24%
Biochemistry, Genetics and Molecular Biology 21 22%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Agricultural and Biological Sciences 5 5%
Unspecified 4 4%
Other 8 8%
Unknown 30 31%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 May 2022.
All research outputs
#7,332,683
of 23,117,738 outputs
Outputs from Journal of Translational Medicine
#1,179
of 4,059 outputs
Outputs of similar age
#139,254
of 406,616 outputs
Outputs of similar age from Journal of Translational Medicine
#19
of 104 outputs
Altmetric has tracked 23,117,738 research outputs across all sources so far. This one has received more attention than most of these and is in the 67th percentile.
So far Altmetric has tracked 4,059 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 406,616 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.
We're also able to compare this research output to 104 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.